Lumosa Therapeutics Co., Ltd. (TPEX:6535)
78.90
+2.70 (3.54%)
Sep 18, 2026, 1:30 PM CST
| Market Cap | 13.21B -75.3% |
| Revenue (ttm) | 34.37M -7.7% |
| Net Income | -370.06M |
| EPS | -2.23 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 360,523 |
| Open | 76.20 |
| Previous Close | 76.20 |
| Day's Range | 76.20 - 78.90 |
| 52-Week Range | 73.70 - 329.50 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 10, 2026 |